Showing results (51-60 of 690) with videos related to
Sort By:
Pageof 69
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 29, 2018
Brain Atrophy in Natalizumab-treated Patients with Multiple Sclerosis: A 5-year Retrospective StudyPhilipp Eisele, Kristina Szabo, Anne Ebert, et al.Current Neurology and Neuroscience Reports|March 8, 2014
Microenvironmental clues for glioma immunotherapyMichael Platten, Katharina Ochs, Dieter Lemke, et al.Cancer Cell|October 20, 2023
Tumor-reactive T helper cells in the context of vaccination against gliomaBinghao Zhao, Michael Kilian, Theresa Bunse, et al.Frontiers in Neurology|November 5, 2019
Characterization of Contrast-Enhancing and Non-contrast-enhancing Multiple Sclerosis Lesions Using Susceptibility-Weighted ImagingPhilipp Eisele, Katja Fischer, Kristina Szabo, et al.BMC Emergency Medicine|October 12, 2019
Uncompleted emergency department care and discharge against medical advice in patients with neurological complaints: a chart reviewCarolin Hoyer, Patrick Stein, Angelika Alonso, et al.Journal of Neuropsychology|May 22, 2021
Impaired semantic memory during acute transient global amnesiaVesile Sandikci, Anne Ebert, Carolin Hoyer, et al.Cancer|June 22, 2010
Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effectsBart Neyns, Alicia Tosoni, Wen-Jen Hwu, et al.Neuro-Oncology|October 31, 2015
Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapyDavid A Reardon, Mark R Gilbert, Wolfgang Wick, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2020
PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?Mustafa Khasraw, David A Reardon, Michael Weller, et al.Expert Opinion on Investigational Drugs|July 12, 2008
Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiformeDavid A Reardon, L Burt Nabors, Roger Stupp, et al.Pageof 69